Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
9 papers
Recent·Most cited
J. J. Rodriguez Galvan, M. de Vries, S. Belblidia, A. Fisher, R. A. Prescott, K. M. Crosse, W. F. Mangel, R. Duerr, M. Dittmann
The paper uses in-silico docking to identify SERPIN targets in SARS-CoV-2, finding novel interactions and validating their role in viral replication.
bioRxiv · Nov 18, 2022 · PreprintMicrobiology
B. A. Rodriguez-Rodriguez, G. Ciabattoni, R. Duerr, A. M. Valero-Jimenez, S. T. Yeung, K. M. Crosse, A. Schinlever, L. Bernard-Raichon, J. J. Rodriguez-Galvan, M. McGrath, S. Vashee, Y. Xue, C. Loomis, K. M. Khanna, K. H. Cadwell, , M. Dittmann
This study establishes a neonatal mouse model to study SARS-CoV-2 transmissibility, showing variant differences in infectious shedding and identifying ORF8's role in transmission.
bioRxiv · Oct 4, 2022 · PreprintMicrobiology
A. Laumaea, L. Marchitto, G. Beaudoin-Bussieres, S. Ding, R. Gasser, D. Chatterjee, G. Gendron-Lepage, H. Medjahed, H.-C. Chen, A. B. Smith, H. Ding, J. C. Kappes, B. H. Hahn, F. Kirchhoff, J. Richard, , A. Finzi
The paper shows that small CD4 mimetics expose ADCC epitopes on HIV-1-infected macrophages, making them susceptible to antibody-dependent cellular cytotoxicity.
bioRxiv · Jun 30, 2022Microbiology
R. Duerr, H. Zhou, T. Tada, D. Dimartino, C. Marier, P. Zappile, G. Wang, J. Plitnick, S. Griesemer, R. C. Girardin, J. Machowski, S. Bialosuknia, E. Lasek-Nesselquist, S. L. Hong, G. Baele, , A. Heguy
This study identifies a Delta-Omicron recombinant SARS-CoV-2 variant that escapes Sotrovimab neutralization, highlighting the role of recombination in immune escape.
bioRxiv · Apr 6, 2022Microbiology
J. Prevost, J. Richard, R. Gasser, H. Medjahed, F. Kirchhoff, B. H. Hahn, J. C. Kappes, C. Ochsenbauer, R. Duerr, A. Finzi
The paper develops a flow cytometry method to detect HIV-1 Nef and Vpu in CD4+ T cells, showing Vpu cannot compensate for Nef absence in ADCC susceptibility.
bioRxiv · Nov 3, 2021Microbiology
A. Tauzin, M. Nayrac, M. Benlarbi, S. Y. Gong, R. Gasser, G. Beaudoin-Bussieres, N. Brassard, A. Laumaea, D. Vezina, J. Prevost, S. P. Anand, C. Bourassa, G. Gendron-Lepage, H. Medjahed, G. Goyette, , A. Finzi
This study shows a single dose of the BNT162b2 mRNA vaccine elicits strong antibody and T cell responses, including Fc-mediated effector functions, and boosts pre-existing immunity in previously infected individuals.
bioRxiv · Mar 18, 2021 · PreprintImmunology
S. P. Anand, J. Prevost, M. Nayrac, G. Beaudoin-Bussieres, M. Benlarbi, R. Gasser, N. Brassard, A. Laumaea, S. Y. Gong, C. Bourassa, E. Brunet-Ratnasingham, H. Medjahed, G. Gendron-Lepage, G. Goyette, L. Gokool, , A. Finzi
This study tracks humoral immune responses in convalescent individuals up to 8 months post-SARS-CoV-2 infection, showing that IgG+ memory B cells persist while plasma antibody levels decline.
bioRxiv · Jan 25, 2021Microbiology
J. Prevost, R. Gasser, G. Beaudoin-Bussieres, J. Richard, R. Duerr, A. Laumaea, S. P. Anand, G. Goyette, M. Benlarbi, S. Ding, H. Medjahed, A. Lewin, J. Perreault, T. Tremblay, G. Gendron-Lepage, , A. Finzi
This study evaluates humoral responses against SARS-CoV-2 Spike in 106 infected individuals, finding persistent RBD-specific IgG and declining neutralizing activity over time.
bioRxiv · Jun 8, 2020Microbiology
L. Liu, L. Li, A. J. Nanfack, L. M. Mayr, S. Soni, A. Kohutnicki, L. A. Agyingi, X.-H. Wang, M. Tuen, Y. Shao, M. Totrov, S. B. Zolla-Pazner, X.-P. Kong, R. Duerr, M. K. Gorny
The paper analyzes anti-V2 antibody levels in HIV-1 infected individuals and finds that some show deficiency, which correlates with viral V2 region characteristics.
bioRxiv · Jun 2, 2018Immunology